Cluster Analysis of Care Pathways in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the USA.

Autor: Zhdanava M; Analysis Group, Inc., Montreal, QC, Canada., Voelker J; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Pilon D; Analysis Group, Inc., Montreal, QC, Canada., Cornwall T; Analysis Group, Inc., Montreal, QC, Canada., Morrison L; Analysis Group, Inc., Montreal, QC, Canada., Vermette-Laforme M; Analysis Group, Inc., Montreal, QC, Canada., Lefebvre P; Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Deloitte Tower, Suite 1500, Montreal, QC, H3B 0G7, Canada. patrick.lefebvre@analysisgroup.com., Nash AI; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Joshi K; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Neslusan C; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
Jazyk: angličtina
Zdroj: PharmacoEconomics [Pharmacoeconomics] 2021 Jun; Vol. 39 (6), pp. 707-720. Date of Electronic Publication: 2021 May 27.
DOI: 10.1007/s40273-021-01042-5
Abstrakt: Background and Objective: Suicidal ideation or behavior are core symptoms of major depressive disorder (MDD). This study aimed to understand heterogeneity among patients with MDD and acute suicidal ideation or behavior.
Methods: Adults with a diagnosis of MDD on the same day or 6 months before a claim for suicidal ideation or behavior (index date) were identified in the MarketScan ® Databases (10/01/2014-04/30/2019). A mathematical algorithm was used to cluster patients on characteristics of care measured pre-index. Patient care pathways were described by cluster during the 12-month pre-index period and up to 12 months post-index.
Results: Among 38,876 patients with MDD and acute suicidal ideation or behavior, three clusters were identified. Across clusters, pre-index exposure to mental healthcare was revealed as a key differentiator: Cluster 1 (N = 16,025) was least exposed, Cluster 2 (N = 5640) moderately exposed, and Cluster 3 (N = 17,211) most exposed. Patients whose MDD diagnosis was first observed during their index event comprised 86.0% and 72.8% of Clusters 1 and 2, respectively; in Cluster 3, all patients had an MDD diagnosis pre-index. Within 30 days post-index, in Clusters 1, 2, and 3, respectively, 79.3%, 85.2%, and 88.2% used mental health services, including outpatient visits for MDD. Within 12 months post-index, 61.5%, 91.5%, and 84.6% had one or more antidepressant claim, respectively. Per-patient index event costs averaged $5614, $6645, and $5853, respectively.
Conclusions: Patients with MDD and acute suicidal ideation or behavior least exposed to the healthcare system pre-index similarly received the least care post-index. An opportunity exists to optimize treatment and follow-up with mental health services.
Databáze: MEDLINE